In Memoriam Tribute to Jack W Coburn, MD: 1932–2004
- 1 December 2004
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 19 (12) , 2089-2090
- https://doi.org/10.1359/jbmr.2004.19.12.2089
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4American Journal of Kidney Diseases, 2004
- A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidismKidney International, 2000
- Bone Aluminum and Histomorphometric Features of Renal Osteodystrophy*Journal of Clinical Endocrinology & Metabolism, 1982
- BONE DISEASE ASSOCIATED WITH TOTAL PARENTERAL NUTRITIONThe Lancet, 1980
- Skeletal Resistance to Endogenous Parathyroid Hormone in Patients with Early Renal Failure. A Possible Cause for Secondary HyperparathyroidismJournal of Clinical Endocrinology & Metabolism, 1975
- Action of 1,25-Dihydroxycholecalciferol, a Potent, Kidney-Produced Metabolite of Vitamin D3, in Uremic ManNew England Journal of Medicine, 1972
- Changes in serum and urinary calcium during phosphate depletion: studies on mechanismsJournal of Clinical Investigation, 1970